Ann Mohrbacher
ONCOLOGY
Associate Professor of Medicine
Keck Medicine of USC
Dr. Ann Mohrbacher has been an associate professor focused on clinical research and treatment of blood cancers at USC for more than 25 years. She has participated in clinical trials of new immunotherapies for lymphoma, leukemia and myeloma. She has collaborated with researchers in early development of new vaccines and antibody constructs and have developed protocols for cellular therapies. One of the earliest trials she worked on led to the first successful and longest standing monoclonal antibody therapy in lymphoma today. She takes particular satisfaction from her long career in developing new treatments in blood cancers and advocating for patient education and equitable access to treatment trials.
